Division of Endocrinology, Diabetes, Metabolism & Nutrition, Mayo Clinic, Rochester, Minnesota.
Clin Endocrinol (Oxf). 2018 Dec;89(6):721-733. doi: 10.1111/cen.13803. Epub 2018 Jul 23.
To identify predictors of hypothalamic-pituitary-adrenal (HPA) axis recovery interval and severity of glucocorticoid withdrawal symptoms (GWS) in patients undergoing adrenalectomy for corticotropin-independent cortisol excess.
This is a retrospective study of patients with mild autonomous cortisol excess (MACE), moderate and severe Cushing syndrome (CS) who developed adrenal insufficiency after unilateral adrenalectomy between 1998 and 2017.
Adrenalectomy was performed in 81 patients (79% women, median age 52 years [IQR 42-62]). HPA axis recovery occurred at a median of 4.3 months (IQR 1.6-11.4) after adrenalectomy (severe CS vs moderate CS vs MACE: median 11.4 vs 2.8 vs 2.1 months, P < 0.01). Main predictors of HPA axis recovery interval included: preoperative serum cortisol concentration after 1-mg overnight dexamethasone suppression test >10 μg/dL or >276 nmol/L (9.7 vs 1.3 months if cortisol ≤10 μg/dL or ≤276 nmol/L, P < 0.01); body mass index (for every 3 kg/m decrease, glucocorticoid taper increased by 1 month, P < 0.05); age <45 (11.4 vs 2.3 months if ≥45 years, P < 0.05); duration of symptoms prior to diagnosis >1 year (11.4 vs 2.8 months if ≤1 year); moon facies (11.4 vs 2.2 months if no rounding of the face); and myopathy (13.1 vs 2.7 months if no myopathy, P < 0.05). Patients with severe CS had a higher incidence of GWS compared to patients with MACE (66.7% vs 40.0%, P < 0.05) with a median of 1 and 0 events/patient, respectively.
The HPA axis recovery interval was the longest for patients with severe CS. Surprisingly, patients with moderate CS recovered their HPA axis as quickly as those with MACE. Glucocorticoid withdrawal symptoms were observed in all groups, with more events in patients with severe CS. This study emphasizes the need to counsel patients on expectations for HPA axis recovery and address intervention for GWS based on individual preoperative parameters.
确定接受肾上腺切除术治疗促肾上腺皮质激素非依赖性皮质醇过多的患者的下丘脑-垂体-肾上腺(HPA)轴恢复时间和糖皮质激素戒断症状(GWS)严重程度的预测因素。
这是一项对 1998 年至 2017 年间单侧肾上腺切除术后发生肾上腺功能不全的轻度自主皮质醇过多(MACE)、中度和重度库欣综合征(CS)患者的回顾性研究。
81 例患者接受了肾上腺切除术(79%为女性,中位年龄 52 岁[四分位距 42-62])。HPA 轴恢复发生在肾上腺切除术后中位数 4.3 个月(四分位距 1.6-11.4)(严重 CS 比中度 CS 比 MACE:中位数 11.4 比 2.8 比 2.1 个月,P<0.01)。HPA 轴恢复间隔的主要预测因素包括:1 毫克过夜地塞米松抑制试验后术前血清皮质醇浓度>10μg/dL 或>276nmol/L(如果皮质醇≤10μg/dL 或≤276nmol/L,则皮质醇为 9.7 比 1.3 个月,P<0.01);体重指数(每减少 3kg/m,皮质类固醇减量增加 1 个月,P<0.05);年龄<45 岁(如果≥45 岁,为 11.4 比 2.3 个月,P<0.05);诊断前症状持续时间>1 年(如果≤1 年,为 11.4 比 2.8 个月);满月脸(如果没有面部变圆,为 11.4 比 2.2 个月);肌病(如果没有肌病,为 13.1 比 2.7 个月,P<0.05)。与 MACE 患者相比,严重 CS 患者的 GWS 发生率更高(66.7%比 40.0%,P<0.05),分别为中位数 1 次和 0 次事件/患者。
严重 CS 患者的 HPA 轴恢复间隔时间最长。令人惊讶的是,中度 CS 患者恢复 HPA 轴的速度与 MACE 患者一样快。所有组均观察到糖皮质激素戒断症状,但严重 CS 患者的事件更多。这项研究强调了需要告知患者对 HPA 轴恢复的期望,并根据个体术前参数解决 GWS 的干预问题。